Medical College of Wisconsin Froedtert Dept of Neurology
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mejaki, Marie
NCT05357989: A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Completed
3
523
Europe, US
buntanetap/posiphen, Posiphen Tartrate, ANVS401, Placebo
Annovis Bio Inc., TFS Trial Form Support
Parkinson's Disease, Idiopathic
12/23
12/23
NuPower, NCT05162768 / 2021-003907-16: Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)

Active, not recruiting
3
102
Europe, US, RoW
Elamipretide, MTP-131, Placebo
Stealth BioTherapeutics Inc.
Mitochondrial Myopathies, Mitochondrial Pathology, Mitochondrial DNA Mutation, Mitochondrial Diseases, Mitochondrial DNA Deletion, Mitochondrial DNA Depletion, Mitochondrial Metabolism Defect, Mitochondrial Complex I Deficiency
09/24
10/24
NCT05721573: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Active, not recruiting
2/3
231
Europe, Canada, US, RoW
ABC008
Abcuro, Inc., Syneos Health
Inclusion Body Myositis
11/25
12/25
REFINE-ALS, NCT04259255: Radicava® (Edaravone) Findings in Biomarkers From ALS

Active, not recruiting
N/A
300
Canada, US
Edaravone (Radicava®/Radicava ORS®), Radicava®, Radicava ORS®
Mitsubishi Tanabe Pharma America Inc., Massachusetts General Hospital
Amyotrophic Lateral Sclerosis, ALS
03/24
03/24

Download Options